{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T10:17:46Z","timestamp":1768558666544,"version":"3.49.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1002\/jps.24652","type":"journal-article","created":{"date-parts":[[2015,9,23]],"date-time":"2015-09-23T20:20:08Z","timestamp":1443039608000},"page":"4217-4222","source":"Crossref","is-referenced-by-count":14,"title":["Investigation of Polycaprolactone Matrices for Intravaginal Delivery of Doxycycline"],"prefix":"10.1016","volume":"104","author":[{"given":"Meenakshi","family":"Pathak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan G.A.","family":"Coombes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark S.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryn","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn J.","family":"Steadman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"40","key":"10.1002\/jps.24652_bb0005","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0968-8080(12)40660-7","article-title":"Global incidence and prevalence of selected curable sexually transmitted infections: 2008","volume":"20","author":"WHO","year":"2012","journal-title":"Reprod Health Matter"},{"issue":"9","key":"10.1002\/jps.24652_bb0010","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/archinte.159.9.1006","article-title":"Doxycycline re-revisited","volume":"159","author":"Cunha","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1002\/jps.24652_bb0015","first-page":"471","article-title":"Safety and efficacy review of doxycycline","volume":"1","author":"Holmes","year":"2009","journal-title":"Clin Med Insights: Ther"},{"issue":"31","key":"10.1002\/jps.24652_bb0020","first-page":"590","article-title":"Update to CDC\u2019s sexually transmitted diseases treatment guidelines, 2010: Oral cephalosporins no longer a recommended treatment for gonococcal infections","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1002\/jps.24652_bb0025","first-page":"197","article-title":"Gonorrhea infection in women: Prevalence, effects, screening, and management","volume":"3","author":"Walker","year":"2011","journal-title":"Int J Womens Health"},{"issue":"10","key":"10.1002\/jps.24652_bb0030","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1258\/ijsa.2011.011267","article-title":"UK national guideline for the management of gonorrhoea in adults, 2011","volume":"22","author":"Bignell","year":"2011","journal-title":"Int J STD AIDS"},{"issue":"8","key":"10.1002\/jps.24652_bb0035","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1177\/0956462413482811","article-title":"2013 UK national guideline for the management of lymphogranuloma venereum: Clinical Effectiveness Group of the British Association for Sexual Health and HIV (CEG\/BASHH) guideline development group","volume":"24","author":"White","year":"2013","journal-title":"Int J STD AIDS"},{"issue":"10","key":"10.1002\/jps.24652_bb0040","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.amjmed.2008.04.042","article-title":"Primary syphilis: Serological treatment response to doxycycline\/tetracycline versus benzathine penicillin","volume":"121","author":"Wong","year":"2008","journal-title":"Am J Med"},{"issue":"1","key":"10.1002\/jps.24652_bb0045","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/QCO.0b013e328334de21","article-title":"Current concepts in managing pelvic inflammatory disease","volume":"23","author":"Judlin","year":"2010","journal-title":"Curr Opin Infect Dis"},{"issue":"2","key":"10.1002\/jps.24652_bb0050","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1442-2050.2004.00384.x","article-title":"Doxycycline-induced pill esophagitis","volume":"17","author":"Kadayifci","year":"2004","journal-title":"Dis Esophagus"},{"issue":"2","key":"10.1002\/jps.24652_bb0055","first-page":"101","article-title":"Doxycycline-induced esophageal ulcers","volume":"63","author":"Huizar","year":"1998","journal-title":"Rev Gastroenterol Mex"},{"issue":"4","key":"10.1002\/jps.24652_bb0060","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1128\/CMR.17.4.783-793.2004","article-title":"Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis","volume":"17","author":"Cudmore","year":"2004","journal-title":"Clin Microbiol Rev"},{"issue":"9","key":"10.1002\/jps.24652_bb0065","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1517\/17425247.2014.924499","article-title":"Vaginal drug delivery: Strategies and concerns in polymeric nanoparticle development","volume":"11","author":"Wong","year":"2014","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"10.1002\/jps.24652_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fertnstert.2004.01.025","article-title":"Why consider vaginal drug administration?","volume":"82","author":"Alexander","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1002\/jps.24652_bb0075","doi-asserted-by":"crossref","first-page":"312","DOI":"10.18433\/J3HP41","article-title":"Strategies to prolong the intravaginal residence time of drug delivery systems","volume":"12","author":"Baloglu","year":"2009","journal-title":"J Pharm Pharm Sci"},{"issue":"2","key":"10.1002\/jps.24652_bb0080","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2147\/TCRM.S1964","article-title":"Review of the combined contraceptive vaginal ring, NuvaRing","volume":"4","author":"Roumen","year":"2008","journal-title":"Ther Clin Risk Manage"},{"issue":"6","key":"10.1002\/jps.24652_bb0085","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.contraception.2007.01.013","article-title":"The contraceptive vaginal ring compared with the combined oral contraceptive pill: A comprehensive review of randomized controlled trials","volume":"75","author":"Roumen","year":"2007","journal-title":"Contraception"},{"issue":"2","key":"10.1002\/jps.24652_bb0090","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4314\/tjpr.v11i2.1","article-title":"Effect of process factors on the properties of doxycycline nanovesicles","volume":"11","author":"Honary","year":"2012","journal-title":"Trop J Pharm Res"},{"issue":"6","key":"10.1002\/jps.24652_bb0095","doi-asserted-by":"crossref","first-page":"274","DOI":"10.17221\/1548-VETMED","article-title":"Correlation analysis of heat stability of veterinary antibiotics by structural degradation, changes in antimicrobial activity and genotoxicity","volume":"56","author":"Hsieh","year":"2011","journal-title":"Vet Med-Czech"},{"issue":"9","key":"10.1002\/jps.24652_bb0100","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/chromsci\/45.9.623","article-title":"Thermostability testing and degradation profiles of doxycycline in bulk, tablets, and capsules by HPLC","volume":"45","author":"Injac","year":"2007","journal-title":"J Chromatogr Sci"},{"issue":"10","key":"10.1002\/jps.24652_bb0105","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.progpolymsci.2010.04.002","article-title":"The return of a forgotten polymer-polycaprolactone in the 21st century","volume":"35","author":"Woodruff","year":"2010","journal-title":"Prog Polym Sci"},{"key":"10.1002\/jps.24652_bb0110","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1002\/jps.24030","article-title":"Evaluation of polycaprolactone matrices for sustained vaginal delivery of nevirapine in the prevention of heterosexual HIV transmission","volume":"103","author":"Dang","year":"2014","journal-title":"J Pharm Sci"},{"issue":"10","key":"10.1002\/jps.24652_bb0115","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1002\/jps.23684","article-title":"An evaluation of polycaprolactone matrices for vaginal delivery of the antiviral, tenofovir, in preventing heterosexual transmission of HIV","volume":"102","author":"Dang","year":"2013","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1002\/jps.24652_bb0120","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jconrel.2005.10.028","article-title":"Delivery of the antibiotic gentamicin sulphate from precipitation cast matrices of polycaprolactone","volume":"110","author":"Chang","year":"2006","journal-title":"J Control Release"},{"issue":"3","key":"10.1002\/jps.24652_bb0125","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1177\/0885328214528256","article-title":"Evaluation of polycaprolactone matrices for the intravaginal delivery of metronidazole in the treatment of bacterial vaginosis","volume":"29","author":"Pathak","year":"2014","journal-title":"J Biomater Appl"},{"issue":"1","key":"10.1002\/jps.24652_bb0130","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/0885328212437393","article-title":"Development of intravaginal matrices from polycaprolactone for sustained release of antimicrobial agents","volume":"28","author":"Dang","year":"2013","journal-title":"J Biomater Appl"},{"key":"10.1002\/jps.24652_bb0135","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0010-7824(99)00010-4","article-title":"A vaginal fluid simulant","volume":"59","author":"Owen","year":"1999","journal-title":"Contraception"},{"key":"10.1002\/jps.24652_bb0140","series-title":"CLSI document M02-A1","article-title":"Performance standards for antimicrobial disk susceptibility tests; Approved standard","author":"CLSI","year":"2012"},{"issue":"3","key":"10.1002\/jps.24652_bb0145","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jconrel.2005.05.013","article-title":"Precipitation casting of drug-loaded microporous PCL matrices: Incorporation of progesterone by co-dissolution","volume":"106","author":"Chang","year":"2005","journal-title":"J Control Release"},{"issue":"8","key":"10.1002\/jps.24652_bb0150","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1021\/cg500877z","article-title":"Protonation pattern, tautomerism, conformerism, and physicochemical analysis in new crystal forms of the antibiotic doxycycline","volume":"14","author":"Santos","year":"2014","journal-title":"Cryst Growth Des"},{"issue":"12","key":"10.1002\/jps.24652_bb0155","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1248\/yakushi.131.1813","article-title":"Formulation optimization and characterization of spray dried microparticles for inhalation delivery of doxycycline hyclate","volume":"131","author":"Mishra","year":"2011","journal-title":"Yakugaku Zasshi"},{"issue":"6","key":"10.1002\/jps.24652_bb0160","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1002\/jps.22027","article-title":"Micro-CT analysis of matrix-type drug delivery devices and correlation with protein release behaviour","volume":"99","author":"Wang","year":"2010","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1002\/jps.24652_bb0165","first-page":"13","article-title":"Liposomal oxytetracycline and doxycycline: Studies on enhancement of encapsulation efficiency","volume":"3","author":"Budai","year":"2009","journal-title":"Drug Discov Ther"},{"issue":"Suppl 4","key":"10.1002\/jps.24652_bb0170","doi-asserted-by":"crossref","first-page":"S309","DOI":"10.1007\/BF01661303","article-title":"Clinical experience with ofloxacin in sexually transmitted disease","volume":"14","author":"Judson","year":"1986","journal-title":"Infection"},{"issue":"2","key":"10.1002\/jps.24652_bb0175","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1517\/14656566.2015.999041","article-title":"Treatment of chlamydial infections: 2014 update","volume":"16","author":"Kohlhoff","year":"2015","journal-title":"Expert Opin Pharmacother"},{"issue":"7","key":"10.1002\/jps.24652_bb0180","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3201\/eid1207.051558","article-title":"Azithromycin failure in mycoplasma genitalium urethritis","volume":"12","author":"Bradshaw","year":"2006","journal-title":"Emerg Infect Dis"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915000787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915000787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T22:35:36Z","timestamp":1567204536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915000787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0022354915000787"],"URL":"https:\/\/doi.org\/10.1002\/jps.24652","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]}}}